Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative bioavailability studies on brands of diazepam tablets.

F A Ogunbona, P A Adedoyin, A A Olaniyi

    African Journal of Medicine and Medical Sciences
    |March 1, 1985
    PubMed
    Summary

    Two diazepam brands, Relanium and Tropium, were compared to Valium in Nigeria. Relanium was bioequivalent, but Tropium showed significant differences, indicating not all generic diazepam tablets are biologically equivalent.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers.

    Journal of clinical pharmacy and therapeutics·2010
    Same author

    Novel determination of nabumetone, a cox-2 inhibitor precursor via its 4-carboxyl-2,6-dinitrobenzene diazonium (CDNBD) derived AZO dye.

    African journal of medicine and medical sciences·2008
    Same author

    Comparative determination of halofantrine tablets by titrimetry, spectrophotometry and liquid chromatography.

    African journal of medicine and medical sciences·2007
    Same author

    Bioequivalence study of three generic formulations of co-trimoxazole tablets in human urine.

    African journal of medicine and medical sciences·2005
    Same author

    Absolute bioavailability of quinine formulations in Nigeria.

    African journal of medicine and medical sciences·2005
    Same author

    Some physicochemical properties of 4-amino-3,5-dinitrobenzoic acid (ADBA).

    African journal of medicine and medical sciences·2004

    Area of Science:

    • Pharmaceutical Sciences
    • Pharmacokinetics
    • Clinical Pharmacology

    Background:

    • Diazepam is a widely used anxiolytic medication.
    • Ensuring bioequivalence of generic drug products is crucial for therapeutic efficacy and patient safety.
    • Marketed diazepam brands in Nigeria require rigorous evaluation for equivalence.

    Purpose of the Study:

    • To assess the chemical and biological equivalence of two diazepam brands (Relanium and Tropium) marketed in Nigeria against the reference product, Valium.
    • To determine if generic diazepam formulations exhibit comparable pharmacokinetic profiles to the originator brand.

    Main Methods:

    • A bioequivalence study was conducted on nine healthy volunteers.
    • Urine samples were collected over 48 hours to monitor the cumulative excretion of diazepam as oxazepam (free and conjugated).

    Related Experiment Videos

  • Statistical analysis was performed to compare the pharmacokinetic profiles of the tested brands against Valium.

    • Main Results:

    • All investigated diazepam products demonstrated chemical equivalence.
    • Relanium (Polfa) was found to be bioequivalent to Valium (Roche).
    • Tropium (Biode) exhibited a statistically significant difference in bioequivalence compared to Valium (P < 0.05).

    Conclusions:

    • The study concludes that while Relanium is bioequivalent to Valium, Tropium is not.
    • This highlights potential variability in the biological equivalence of generic diazepam products available in the Nigerian market.
    • Regulatory bodies must ensure stringent bioequivalence testing for all marketed generic pharmaceuticals.